The NovoCare Patient Assistance Program (PAP) helps low-income individuals who are uninsured or underinsured and cannot afford their medications
Its actual prevalence can vary significantly according to the population that is being investigated and the definition criteria that are applied [2, 3]
New interpretation of oral glucose tolerance
As their use has expanded, questions about potential cancer risks have emerged, prompting both patients and healthcare providers to seek clarity on the safety profile of these medications
Bariatric surgery is a single procedure, but success depends on consistent follow-up care, nutritional supplementation, and a commitment to healthy living
Because the prevalence of CVD in the population with T2DM is around 32% [33], at least one fourth of the average patient with T2DM is possible a candidate for the use of the GLP-1RA, or sodium-glucose transporter-2 inhibitors [34], to improve the MACE outcome